IMNM R&D Expenses

Immunome Inc · R&D Expenses

IMNM logo

IMNM R&D Expenses

Latest reported$59.89M
IMNM Quarterly R&D Expenses ($2.08M → $59.89M)
High-resolution chart · PNG

IMNM r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunome Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
59,885,000
46,381,000
60,770,000
49,193,000
40,451,000
36,872,000
47,890,000
37,200,000
29,083,000
15,369,000
9,637,000
3,823,000
5,716,000
3,913,000
4,252,000
5,225,000
5,717,000
8,078,000
4,385,000
4,513,000
3,233,000
1,979,000
1,835,000
1,644,000
1,892,000
2,115,000
2,432,000
2,234,000
2,078,500
2,078,500
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.